Economic information and modeling reportBudget impact model
Approach and framework
1 evidence topic · 1 source
Saroglitazar
Primary biliary cholangitis
- Manufacturer
- Zydus Therapeutics
- Regulatory submission
- NDA submitted by May 2026
- Last updated
Primary biliary cholangitis
Economic information and modeling reportBudget impact model
1 evidence topic · 1 source